.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Chubb
Chinese Patent Office
Queensland Health
Harvard Business School
QuintilesIMS
Express Scripts
Covington
Colorcon
Novartis

Generated: July 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040320

« Back to Dashboard
NDA 040320 describes TAPAZOLE, which is a drug marketed by King Pharms and King Pharms Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the TAPAZOLE profile page.

The generic ingredient in TAPAZOLE is methimazole. There are three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the methimazole profile page.

Summary for NDA: 040320

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Hormonal Agents, Suppressant (Thyroid)
Formulation / Manufacturing:see details

Pharmacology for NDA: 040320

Mechanism of ActionThyroid Hormone Synthesis Inhibitors

Suppliers and Packaging for NDA: 040320

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TAPAZOLE
methimazole
 TABLET;ORAL 040320 ANDA Pfizer Laboratories Div Pfizer Inc 60793-104 60793-104-01 100 TABLET in 1 BOTTLE (60793-104-01)
TAPAZOLE
methimazole
 TABLET;ORAL 040320 ANDA Pfizer Laboratories Div Pfizer Inc 60793-105 60793-105-01 100 TABLET in 1 BOTTLE (60793-105-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Mar 31, 2000TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Mar 31, 2000TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
US Army
Boehringer Ingelheim
Fuji
Express Scripts
Federal Trade Commission
Medtronic
Mallinckrodt
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot